Skip to main content

Uncertainty quantification in multi-parametric MRI-based meningioma radiotherapy target segmentation.

Publication ,  Journal Article
Wang, L; Yang, Z; LaBella, D; Reitman, Z; Ginn, J; Zhao, J; Adamson, J; Lafata, K; Calabrese, E; Kirkpatrick, J; Wang, C
Published in: Front Oncol
2025

PURPOSE: This work investigates the use of a spherical projection-based U-Net (SPU-Net) segmentation model to improve meningioma segmentation performance and allow for uncertainty quantification. METHODS: A total of 76 supratentorial meningioma patients treated with radiotherapy were studied. Gross tumor volumes (GTVs) were contoured by a single experienced radiation oncologist on high-resolution contrast-enhanced T1 MRI scans (T1ce), and both T1 and T1ce images were utilized for segmentation. SPU-Net, an adaptation of U-Net incorporating spherical image projection to map 2D images onto a spherical surface, was proposed. As an equivalence of a nonlinear image transform, projections enhance locoregional details while maintaining the global field of view. By employing multiple projection centers, SPU-Net generates various GTV segmentation predictions, the variance indicating the model's uncertainty. This uncertainty is quantified on a pixel-wise basis using entropy calculations and aggregated through Otsu's method for a final segmentation. RESULTS/CONCLUSION: The SPU-Net model poses an advantage over traditional U-Net models by providing a quantitative method of displaying segmentation uncertainty. Regarding segmentation performance, SPU-Net demonstrated comparable results to a traditional U-Net in sensitivity (0.758 vs. 0.746), Dice similarity coefficient (0.760 vs. 0.742), reduced mean Hausdorff distance (mHD) (0.612 cm vs 0.744 cm), and reduced 95% Hausdorff distance (HD95) (2.682 cm vs 2.912 cm). SPU-Net not only is comparable to U-Net in segmentation performance but also offers a significant advantage by providing uncertainty quantification. The added SPU-Net uncertainty mapping revealed low uncertainty in accurate segments (e.g., within GTV or healthy tissue) and higher uncertainty in problematic areas (e.g., GTV boundaries, dural tail), providing valuable insights for potential manual corrections. This advancement is particularly valuable given the complex extra-axial nature of meningiomas and involvement with dural tissue. The capability to quantify uncertainty makes SPU-Net a more advanced and informative tool for segmentation, without sacrificing performance.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Front Oncol

DOI

ISSN

2234-943X

Publication Date

2025

Volume

15

Start / End Page

1474590

Location

Switzerland

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, L., Yang, Z., LaBella, D., Reitman, Z., Ginn, J., Zhao, J., … Wang, C. (2025). Uncertainty quantification in multi-parametric MRI-based meningioma radiotherapy target segmentation. Front Oncol, 15, 1474590. https://doi.org/10.3389/fonc.2025.1474590
Wang, Lana, Zhenyu Yang, Dominic LaBella, Zachary Reitman, John Ginn, Jingtong Zhao, Justus Adamson, et al. “Uncertainty quantification in multi-parametric MRI-based meningioma radiotherapy target segmentation.Front Oncol 15 (2025): 1474590. https://doi.org/10.3389/fonc.2025.1474590.
Wang L, Yang Z, LaBella D, Reitman Z, Ginn J, Zhao J, et al. Uncertainty quantification in multi-parametric MRI-based meningioma radiotherapy target segmentation. Front Oncol. 2025;15:1474590.
Wang, Lana, et al. “Uncertainty quantification in multi-parametric MRI-based meningioma radiotherapy target segmentation.Front Oncol, vol. 15, 2025, p. 1474590. Pubmed, doi:10.3389/fonc.2025.1474590.
Wang L, Yang Z, LaBella D, Reitman Z, Ginn J, Zhao J, Adamson J, Lafata K, Calabrese E, Kirkpatrick J, Wang C. Uncertainty quantification in multi-parametric MRI-based meningioma radiotherapy target segmentation. Front Oncol. 2025;15:1474590.

Published In

Front Oncol

DOI

ISSN

2234-943X

Publication Date

2025

Volume

15

Start / End Page

1474590

Location

Switzerland

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis